Emsam and Visual acuity reduced - a phase IV clinical study of FDA data
Visual acuity reduced is reported only by a few people who take Emsam.
The phase IV clinical study analyzes which people take Emsam and have Visual acuity reduced. It is created by eHealthMe based on reports of 1,591 people who have side effects while taking Emsam from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,591 people reported to have side effects when taking Emsam.
Among them, 2 people (0.13%) have Visual acuity reduced.
What is Emsam?
Emsam has active ingredients of selegiline. It is often used in depression. eHealthMe is studying from 1,815 Emsam users for its effectiveness, alternative drugs and more.
What is Visual acuity reduced?
Visual acuity reduced (reduced clearness of vision) is found to be associated with 2,421 drugs and 1,852 conditions by eHealthMe.
Number of Emsam and Visual acuity reduced reports submitted per year:
Gender of people who have Visual acuity reduced when taking Emsam *:
- female: 100 %
- male: 0.0 %
Common drugs people take besides Emsam *:
- Zetia: 1 person, 50.00%
- Synthroid: 1 person, 50.00%
- Motrin: 1 person, 50.00%
- Geodon: 1 person, 50.00%
Common side effects people have besides Visual acuity reduced *:
- Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 50.00%
- Pruritus Generalised (generalized itching): 1 person, 50.00%
- Migraine (headache): 1 person, 50.00%
- Insomnia (sleeplessness): 1 person, 50.00%
- Generalised Erythema (redness of the skin all over the body): 1 person, 50.00%
- Fear: 1 person, 50.00%
- Diplopia (double vision): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Emsam and have Visual acuity reduced?Check whether Visual acuity reduced is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Visual acuity reduced and when was it recovered:
Expand to all the drugs that have ingredients of selegiline:
Alternative drugs to, pros and cons of Emsam:
- Emsam (1,815 reports)
Common Emsam side effects:
- Drug ineffective: 188 reports
- Insomnia (sleeplessness): 147 reports
- Depression: 121 reports
- Stress and anxiety: 102 reports
Browse all side effects of Emsam:a b c d e f g h i j k l m n o p q r s t u v w x y z
Visual acuity reduced treatments and more:
- Visual acuity reduced (43,517 reports)
COVID vaccines that are related to Visual acuity reduced:
- Visual acuity reduced in Moderna COVID Vaccine
- Visual acuity reduced in Pfizer BioNTech Covid Vaccine
- Visual acuity reduced in Johnson and Johnson Covid Vaccine
Common drugs associated with Visual acuity reduced:
- Lucentis: 2,932 reports
- Humalog: 2,249 reports
- Lantus: 1,982 reports
- Aspirin: 1,715 reports
- Prednisone: 1,239 reports
- Metformin: 1,162 reports
- Lyrica: 1,154 reports
- Avonex: 1,073 reports
- Eylea: 1,040 reports
- Lisinopril: 986 reports
All the drugs that are associated with Visual acuity reduced:
- Visual acuity reduced (2,421 drugs)
Common conditions associated with Visual acuity reduced:
- Multiple sclerosis: 3,225 reports
- Diabetes: 1,904 reports
- Type 2 diabetes: 1,705 reports
- High blood pressure: 1,609 reports
All the conditions that are associated with Visual acuity reduced:
- Visual acuity reduced (1,852 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on selegiline (the active ingredients of Emsam) and Emsam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Anzemet and Fungal Nail Infection - 2 seconds ago
- Glucotrol and Bone Neoplasm Malignant - 3 seconds ago
- Novolin N and Arimidex drug interaction - 5 seconds ago
- Abacavir Sulfate and Femoral Neck Fracture - 9 seconds ago
- Glucotrol and Borderline Glaucoma - 10 seconds ago
- Renal Cell Carcinoma Stage Unspecified and Nausea And Vomiting - 11 seconds ago
- Lantus and Macular Degeneration - 16 seconds ago
- Simethicone and Dizziness - 19 seconds ago
- Stress And Anxiety and Bi-Polar - 27 seconds ago
- Stress And Anxiety and Bipolar Disorder - 27 seconds ago